Liposomes as vehicles for water insoluble platinum-based potential drug: 2-(4-(Tetrahydro-2H-pyran-2-yloxy)-undecyl)-propane-1,3- diamminedichloroplatinum(II)

European Journal of Medicinal Chemistry

Volumn 54, Issue , 2012, Pages 567-572

  Kaluerović, Goran N ^a   Dietrich, Andrea ^a   Kommera, Harish ^a   Kuntsche, Judith ^a   Mäder, Karsten ^a   Mueller, Thomas ^a   Paschke, Reinhard ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Antitumoral activity; Cisplatin; Liposomes; Platinum(II) complexes; Selectivity

Indexed keywords

2 [4 (TETRAHYDRO 2H PYRAN 2 YLOXY)UNDECYL]PROPANE 1,3 DIAMMINEDICHLOROPLATINUM; ANTINEOPLASTIC AGENT; CISPLATIN; DRUG VEHICLE; LIPOSOME; PHOSPHATIDYLCHOLINE; PLATINUM DERIVATIVE; UNCLASSIFIED DRUG;

ANALYTIC METHOD; ANTIPROLIFERATIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DISPERSION; DRUG FORMULATION; DRUG SOLUBILITY; DRUG STABILITY; DYNAMIC LIGHT SCATTERING; FIBROBLAST; FIELD FLOW FRACTIONATION; HUMAN; HUMAN CELL; IC 50; LIGHT SCATTERING; LIPOSOMAL DELIVERY; MALE; PARTICLE SIZE; THERMOSTABILITY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; HUMANS; INHIBITORY CONCENTRATION 50; LIPOSOMES; ORGANOPLATINUM COMPOUNDS; SOLUBILITY; WATER;

EID: 84864411185     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2012.06.004     Document Type: Article

References (33)

1. T.W. Hambley, A.R. Battle, G.B. Deacon, E.T. Lawrenz, G.D. Fallon, B.M. Gatehouse, L.K. Webster, and S. Rainone J. Inorg. Biochem. 77 1999 3 12
2. S. Aranelović, Ž.L. Tešić, and S.S. Radulović Med. Chem. Rev. 2 2005 415 422
3. L. Kelland Nat. Rev. Cancer 7 2007 573 584
4. R. Paschke, J. Kalbitz, C. Paetz, M. Luckner, T. Mueller, H.J. Schmoll, H. Mueller, E. Sorkau, and E. Sinn J. Inorg. Biochem. 94 2003 335 342
5. T. Servidei, C. Ferlini, A. Riccardi, D. Meco, G. Scambia, G. Segni, C. Manzotti, and R. Riccardi Europ. J. Cancer 37 1990 930 938
6. G.N. Kaluerović, and R. Paschke Curr. Med. Chem. 18 2011 4738 4752
7. G. Natile, and M. Coluccia Coord. Chem. Rev. 216-217 2001 383 410
8. T. Boulikas, and M. Vougiouka Oncol. Rep. 10 2003 1663 1682
9. J. Zhang, D. Liu, Y. Li, J. Sun, L. Wang, and A. Zang Mini Rev. Med. Chem. 9 2009 1357 1366
10. J.T. Hartmann, and H.P. Lipp Expert Opin. Pharmacother. 4 2003 889 901
11. V.K. Yellepeddi, A. Kumar, D.M. Maher, S.C. Chauhan, K.K. Vangara, and S. Palakurthi Anticancer Res. 31 2011 897 906
12. I. Ali, U. Rahis, K. Salim, M.A. Rather, W.A. Wani, and A. Haque Curr. Cancer Drug Targets 11 2011 135 146
13. A. Kowalczuk, E. Stoyanova, V. Mitova, P. Shestakova, G. Momekov, D. Momekova, and N. Koseva Int. J. Pharm. 404 2011 220 230
14. I. Winer, S. Wang, Y.E. Lee, W. Fan, Y. Gong, D. Burgos-Ojeda, G. Spahlinger, R. Kopelman, and R.J. Buckanovich Cancer Res. 70 2010 8674 8683
15. Y. Min, C. Mao, D. Xu, J. Wang, and Y. Liu Chem. Commun. 46 2010 8424 8426
16. R. Guo, L. Zhang, H. Qian, R. Li, X. Jiang, and B. Liu Langmuir 26 2010 5428 5434
17. B. Thierry, F. Al-Ejeh, A. Khatri, Z. Yuan, P.J. Russell, S. Ping, M.P. Brown, and P. Majewski Chem. Commun. 2009 7348 7350
18. M.J. de Jonge, M. Slingerland, W.J. Loos, E.A. Wiemer, H. Burger, R.H. Mathijssen, J.R. Kroep, M.A. den Hollander, B.D. van der, M.H. Lam, J. Verweij, and H. Gelderblom Eur. J. Cancer 46 2010 3016 3021
19. B.W. Harper, A.M. Krause-Heuer, M.P. Grant, M. Manohar, K.B. Garbutcheon-Singh, and J.R. Drich-Wright Chemistry 16 2010 7064 7077
20. T. Tippayamontri, R. Kotb, B. Paquette, and L. Sanche Invest. New Drugs 29 2011 1321 1327
21. G.C. dos Santos, E.C. de Oliveira Reis, T.G. Ribeiro Rocha, E.A. Leite, R.G. Lacerda, G.A. Ramaldes, and M.C. De Oliveira J. Liposome Res. 21 2011 60 69
22. M.L. Krieger, N. Eckstein, V. Schneider, M. Koch, H.D. Royer, U. Jaehde, and G. Bendas Int. J. Pharm. 389 2010 10 17
23. R. Schobert, B. Biersack, A. Dietrich, A. Grotemeier, T. Muller, B. Kalinowski, S. Knauer, W. Voigt, and R. Paschke J. Med. Chem. 50 2007 1288 1293
24. H. Kommera, G.N. Kaluerović, J. Kalbitz, B. Drager, and R. Paschke Eur. J. Med. Chem. 45 2010 3346 3353
25. A. Dietrich, T. Mueller, R. Paschke, B. Kalinowski, T. Behlendorf, F. Reipsch, A. Fruehauf, H.J. Schmoll, C. Kloft, and W. Voigt J. Med. Chem. 51 2008 5413 5422
26. A. Schädlich, C. Rose, J. Kuntsche, H. Caysa, T. Mueller, A. Göpferich, and K. Mäder Pharm. Res. 28 2011 1995 2007
27. A. Schädlich, H. Caysa, T. Mueller, F. Tenambergen, C. Rose, A. Göpferich, J. Kuntsche, and K. Mäder ACS Nano 5 2011 8710 8720
28. A. Fahr, P. van Hoogevest, S. May, N. Bergstrand, and M.L.S. Leigh Eur. J. Pharm. Sci. 26 2005 251 265
29. A.D. Sezer, A.L. Bas, and J. Akbuga J. Liposome Res. 14 2004 77 86
30. J. Kuntsche, K. Klaus, and F. Steiniger J. Biomed. Nanotechnol. 5 2009 384 395
31. O. Stauch, R. Schubert, G. Savin, and W. Burchard Biomacromolecules 3 2002 565 578
32. P.J. Wyatt J. Colloid Interface Sci. 197 1998 9 20
33. P. Skehan, R. Storeng, D. Scudiero, A. Monks, J. McMahon, D. Vistica, J.T. Warren, H. Bokesch, S. Kenney, and M.R. Boyd J. Natl. Cancer Inst. 82 1990 1107 1112